Human Reproduction, Vol. 17, No. 8, 1994-1996,
August 2002
© 2002 European Society of Human Reproduction and Embryology
Metabolic characteristics of women who developed ovarian hyperstimulation syndrome
1 Departments of Obstetrics and Gynaecology, IVF and Haematology, St Pierre University Hospital, Free University of Brussels, Rue Haute, 322, 1000 Brussels, 2 Department of Medical Genetics and Institute of Interdisciplinary Research, Faculty of Medicine, Free University of Brussels, 1070 Brussels, 3 IVF Center, Institut Médical E. Cavell, Rue Edith Cavell 32, 1080 Brussels and 4 Department of Clinical Chemistry, University Hospital Brugmann, 4 Place Van Gehuchten, Free University of Brussels, 1020 Brussels, Belgium
BACKGROUND: The aim of this study was to investigate whether a higher incidence of hyperinsulinism is found in women who have suffered from ovarian hyperstimulation syndrome (OHSS) as compared with other IVF patients. Additionally, we also assessed whether any abnormalities in the haemostatic system were more frequent in women with a past history of OHSS. METHODS: A pilot study was carried out involving OHSS patients and matched IVF patients. Homeostasis model assessment (HOMA) of insulin sensitivity was calculated. The main outcome measures were: insulin sensitivity, coagulation anomalies, factor V Leiden mutations, methylene tetrahydrofolate reductase (MTHFR) polymorphism and prothrombin gene mutation, protein C and protein S deficiency. RESULTS: No increased incidence in hyperinsulism nor in abnormalities of the haemostatic system were observed. CONCLUSIONS: This pilot study does not provide evidence for an increased prevalence of hyperinsulinism among women who have developed OHSS in the past.
Key words: insulin resistance/IVF/ovarian hyperstimulation syndrome (OHSS)
5 To whom correspondence should be addressed. E-mail: annickdelvigne{at}swing.be
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wiser, J. Levron, D. Kreizer, R. Achiron, A. Shrim, E. Schiff, J. Dor, and A. Shulman Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester Hum. Reprod., April 1, 2005; 20(4): 910 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saisto, A. Tiitinen, V.-M. Ulander, and R. Kaaja Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia Hum. Reprod., March 1, 2004; 19(3): 725 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Ou, Y.-L. Kao, S.-L. Lai, F.-T. Kung, F.-J. Huang, S.-Y. Chang, and C.-C. ChangChien Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report Hum. Reprod., November 1, 2003; 18(11): 2375 - 2381. [Abstract] [Full Text] [PDF] |
||||

